✦ LIBER ✦

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes

✍ Scribed by J. Rosenstock; S. Sankoh; J. F. List

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB

The dipeptidyl peptidase-4 inhibitor PHX

✍ G. Garcia-Soria; G. Gonzalez-Galvez; G. M. Argoud; M. Gerstman; T. W. Littlejohn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INH

✍ Sara Stafford; Dariush Elahi; Graydon S. Meneilly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Dipeptidyl peptidase-4 inhibitors in the

✍ C. F. Deacon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB